MHS4 |
|
malignant hyperthermia susceptibility 4
|
|
|
0.890 |
0.154 |
BCL5 |
|
B cell CLL/lymphoma 5
|
|
|
0.890 |
0.154 |
C11orf58 |
O00193
|
chromosome 11 open reading frame 58
|
|
0.17 |
0.861 |
0.154 |
ZNF7 |
P17097
|
zinc finger protein 7
|
|
2.1E-07 |
0.861 |
0.192 |
FRA8C |
|
fragile site, aphidicolin type, common, fra(8)(q24.1)
|
|
|
0.861 |
0.192 |
IGLC4 |
|
immunoglobulin lambda constant 4 (pseudogene)
|
|
|
0.839 |
0.385 |
IGLC5 |
|
immunoglobulin lambda constant 5 (pseudogene)
|
|
|
0.839 |
0.385 |
IGLC6 |
P0CF74
|
immunoglobulin lambda constant 6 (gene/pseudogene)
|
|
|
0.839 |
0.385 |
VPREB3 |
Q9UKI3
|
V-set pre-B cell surrogate light chain 3
|
Immune response
|
9.5E-02 |
0.821 |
0.192 |
IGLC1 |
P0CG04
|
immunoglobulin lambda constant 1
|
|
|
0.821 |
0.385 |
IGLC3 |
P0DOY3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker)
|
|
|
0.821 |
0.423 |
QPCTL |
Q9NXS2
|
glutaminyl-peptide cyclotransferase like
|
Enzyme
|
1.6E-08 |
0.805 |
0.346 |
DEL13Q14 |
|
Chromosome 13q14 deletion syndrome
|
|
|
0.805 |
0.192 |
RNA28SN4 |
|
RNA, 28S ribosomal N4
|
|
|
0.805 |
0.231 |
RNA28S5 |
|
RNA, 28S ribosomal 5
|
|
|
0.805 |
0.231 |
BCRP4 |
|
BCR pseudogene 4
|
|
|
0.805 |
0.154 |
IGLC2 |
P0DOY2
|
immunoglobulin lambda constant 2
|
|
|
0.805 |
0.462 |
FAU |
P35544
|
FAU ubiquitin like and ribosomal protein S30 fusion
|
|
0.85 |
0.792 |
0.269 |
PIK3AP1 |
Q6ZUJ8
|
phosphoinositide-3-kinase adaptor protein 1
|
|
1.00 |
0.780 |
0.346 |
MIR1204 |
|
microRNA 1204
|
|
|
0.769 |
0.423 |
MIR4728 |
|
microRNA 4728
|
|
|
0.769 |
0.269 |
IGHV3-75 |
|
immunoglobulin heavy variable 3-75 (pseudogene)
|
|
|
0.769 |
0.231 |
SERPINA9 |
Q86WD7
|
serpin family A member 9
|
Enzyme modulator
|
1.2E-13 |
0.769 |
0.231 |
RGS13 |
O14921
|
regulator of G protein signaling 13
|
Enzyme modulator
|
4.5E-04 |
0.769 |
0.423 |
KIFAP3 |
Q92845
|
kinesin associated protein 3
|
Cellular structure
|
1.6E-05 |
0.760 |
0.346 |